Through further clinical and genome- wide association studies, GBA mutations are now recognized to increase the risk of developing PD by at least 5-fold compared to non-carriers making GBA mutations the strongest genetic risk factor for PD (Sidransky et al., 2009; Nalls et al., 2013). Here, GBA1 is linked to Parkinson disease.